ACTIVE SUBSTANCE / INN

RIBOFLAVIN 5'-PHOSPHATE SODIUM

Brand name(s): BEROCCA PN, M.V.I. PEDIATRIC, M.V.I.-12 ADULT, M.V.I. ADULT, M.V.I.-12 LYOPHILIZED, M.V.C. 9+3, M.V.I. ADULT (PHARMACY BULK PACKAGE), INFUVITE ADULT, MVC PLUS, PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA021163
NDA006071
ACTIVE SUBSTANCE
Riboflavin 5'-Phosphate Sodium
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, GLAUKOS, ROCHE
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
INFUVITE ADULTNDA021163SANDOZ CANADA INCPrescription
M.V.I.-12 LYOPHILIZEDNDA018933TELIGENTDiscontinued
MVC PLUSNDA018439WATSON LABSDiscontinued
M.V.C. 9+3NDA018440ABRAXIS PHARMDiscontinued
PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXANDA203324GLAUKOSPrescription
M.V.I.-12 ADULTNDA008809HOSPIRADiscontinued
M.V.I. ADULT (PHARMACY BULK PACKAGE)NDA021643HOSPIRADiscontinued
BEROCCA PNNDA006071ROCHEDiscontinued
M.V.I. PEDIATRICNDA018920HOSPIRADiscontinued
M.V.I. ADULTNDA021625HOSPIRADiscontinued

FULL INTELLIGENCE ON RIBOFLAVIN 5'-PHOSPHATE SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →